60 Degrees Pharmaceuticals Inc. (SXTP)
(Delayed Data from NSDQ)
$1.35 USD
-0.04 (-2.54%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $1.34 -0.01 (-0.37%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
60 Degrees Pharmaceuticals Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
SXTP 1.35 -0.04(-2.54%)
Will SXTP be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SXTP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SXTP
Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates
Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates
SXTP: What are Zacks experts saying now?
Zacks Private Portfolio Services
60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q3 Loss, Misses Revenue Estimates
VAXART, INC. (VXRT) Reports Q3 Loss, Tops Revenue Estimates
OptiNose (OPTN) Reports Break-Even Earnings for Q3
Other News for SXTP
60 Degrees Pharmaceuticals (SXTP) Partners with Tulane University for Lyme Disease Research | ...
60 Degrees Pharmaceuticals and Tulane University Sign Research Agreement to Study Tafenoquine ...
60 Degrees Pharmaceuticals, Tulane University sign research agreement
12 Health Care Stocks Moving In Tuesday's Intraday Session
60 Degrees Pharmaceuticals (SXTP) Announces Public Offering Details